A five year training program is proposed to develop a career in academic cardiology with a focus on pulmonary vascular function and disease. The principal investigator is a graduate of the Medical Scientist Training Program and has completed residency training in Internal Medicine and fellowship training in Cardiology (Massachusetts General Hospital, MGH). Dr. Joseph Loscalzo will serve as the primary laboratory mentor and is a recognized expert and scientific leader in vascular biology. He has successfully trained numerous postdoctoral fellows, many of whom have gone on to major scientific and leadership roles in biomedical sciences. An advisory panel of expert medical scientists will also provide further scientific and career guidance. By combining the resources of multiple Harvard-affiliated programs, this training environment is ideal to cultivate a successful research program on which to base a productive future career. The principal investigator has identified the hypoxia-induced microRNA-210 (miR-210) as a novel and essential regulator of mitochondrial metabolism and cellular respiration in hypoxic pulmonary arterial endothelial cells, via repression of the iron-sulfur cluster assembly proteins ISCU1/2. This proposal will interrogate a model whereby control of endothelial-specific phenotypes in the pulmonary vasculature depends critically upon the down-regulation of ISCU1/2 and iron-sulfur clusters by miR-210. Under conditions of normoxia and hypoxia, experiments will entail expression of miR-210 and inhibition of miR-210 in cultured pulmonary arterial endothelial cells as well as in the pulmonary vasculature of murine subjects. Phenotypes will be assessed by a combination of molecular, genetic, biochemical, and biophysical techniques. Proposed experiments listed under """"""""Specific Aims"""""""" will elucidate the role of miR-210, ISCU1/2, and iron-sulfur clusters in the regulation of: 1) mitochondrial electron transport;2) reactive oxygen species flux;and 3) nitric oxide bioavailability. Results will improve our molecular understanding of physiologic and pathophysiologic adaptations in the hypoxic pulmonary vasculature and may point to novel therapeutic targets.

Public Health Relevance

This proposal will define the critical actions of a novel molecule (microRNA-210) in regulating the response to low oxygen exposure in cells that line the blood vessels of the lungs. In doing so, it is expected to improve the current understanding of the mechanisms by which low oxygen conditions affect the pulmonary vessels during normal and disease states and may point to future therapeutic targets.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL096834-05
Application #
8457092
Study Section
Special Emphasis Panel (ZHL1-CSR-U (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2010-04-01
Project End
2015-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
5
Fiscal Year
2013
Total Cost
$137,445
Indirect Cost
$10,070
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Florentin, Jonathan; Coppin, Emilie; Vasamsetti, Sathish Babu et al. (2018) Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes. J Immunol 200:3612-3625
Masri, Ahmad; Abdelkarim, Islam; Sharbaugh, Michael S et al. (2018) Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement. Heart 104:821-827
Chun, Hyung J; Bonnet, Sebastien; Chan, Stephen Y (2017) Reply: Transforming Growth Factor ?1- and Bone Morphogenetic Protein 2/PPAR?-regulated MicroRNAs in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 196:1228-1229
Chan, Stephen Y; Snow, Jonathan W (2017) Formidable challenges to the notion of biologically important roles for dietary small RNAs in ingesting mammals. Genes Nutr 12:13
Chun, Hyung J; Bonnet, S├ębastien; Chan, Stephen Y (2017) Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than ""miR"" Words. Am J Respir Crit Care Med 195:167-178
Chan, Stephen Y; Rubin, Lewis J (2017) Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice. Eur Respir Rev 26:
Yu, Qiujun; Chan, Stephen Y (2017) Mitochondrial and Metabolic Drivers of Pulmonary Vascular Endothelial Dysfunction in Pulmonary Hypertension. Adv Exp Med Biol 967:373-383
Bertero, Thomas; Oldham, William M; Cottrill, Katherine A et al. (2016) Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J Clin Invest 126:3313-35
Bertero, Thomas; Cottrill, Katherine; Krauszman, Adrienn et al. (2015) The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension. J Biol Chem 290:2069-85
Bertero, Thomas; Cottrill, Katherine A; Lu, Yu et al. (2015) Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit. Cell Rep 13:1016-32

Showing the most recent 10 out of 35 publications